Delivery Order SPE2DB20D3303-SPE2DB24FZ4F8
- Not listed
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the pharmaceutical distribution company Amerisourcebergen Corporation. The $12,636.06 firm fixed price delivery order is for Trelegy Ellipta 100-62.5-25 60S, a specialty pharmaceutical product. Amerisourcebergen Drug Corp is the prime contractor on a larger indefinite delivery contract (IDC) with DLA valued at up to $999,999,999.00 through December 31, 2025. This IDC...
- The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of Trelegy Ellipta 100-62.5-25 60S pharmaceutical product. The award, valued at $9,144.90, has an ultimate completion date of March 21, 2024. Amerisourcebergen Drug Corp is the prime contractor and this award is a child of a larger indefinite delivery contract (IDC) with a potential value of up to...
- This federal contract award is for the delivery of Trelegy Ellipta 100-62.5-25 60S pharmaceuticals to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution company. The contract is a firm fixed price delivery order with a ceiling value of $6,170.36 and a performance period through March 15, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery...
- This federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, is for the delivery of Trelegy Ellipta 100-62.5-25 60S, a pharmaceutical product, over the period from February 3, 2025 to February 4, 2025. The contract has a ceiling value of $5,578.92 and is a Firm Fixed Price Delivery Order. The contract was not set aside for any special program. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with...
- This federal contract award is a delivery order with a ceiling value of $3,284.49 issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Trelegy Ellipta 200-62.5-25 60S, a pharmaceutical product, with a period of performance through September 20, 2023. The contract has a firm fixed price pricing type and is not designated under any set-aside program. Amerisourcebergen...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The award is a firm fixed price delivery order for the supply of TRELEGY ELLIPTA 200-62.5-25 60S, a specialty pharmaceutical product. The contract has a ceiling value of $1,493.92 and a period of performance through April 12, 2024. Amerisourcebergen Drug Corp is the...
- This federal contract award, with a ceiling value of $2,819.29, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of TRELEGY ELLIPTA 100-62.5-25 60S, a pharmaceutical product, with a period of performance through May 15, 2025. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation, indicating open competition. Amerisourcebergen Drug...
- This federal contract award is for the delivery of TRELEGY ELLIPTA 200-62.5-25 60S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The award was made to the Amerisourcebergen Drug Corp, a major pharmaceutical supplier to the U.S. government. The contract has a ceiling value of $24,971.49 and is a Firm Fixed Price Delivery Order that will be completed by April 24, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $16,093.07 delivery order contract is for the provision of Trelegy Ellipta 100-62.5-25 60S, a pharmaceutical product, with a completion date of April 17, 2025. The contract is a firm fixed-price, non-set-aside award, indicating open competition. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The $7,503.84 firm fixed price delivery order is for the supply of TRELEGY ELLIPTA 100-62.5-25 60S, a prescription pharmaceutical product. This award is a part of Amerisourcebergen Drug Corp's larger indefinite delivery contract (IDC) with DLA, valued at up to...
- SPE2DB20D3303Indefinite Delivery Contract
- SPE2DB20D3303-SPE2DB24FZ4F8Delivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract is for the delivery of Trelegy Ellipta 200-62.5-25 60s pharmaceutical product, with a ceiling value of $7,340.96 and a performance period through April 11, 2024. The contract is a firm fixed price delivery order and is not associated with any set-aside designation. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA with a potential value of up to $999,999,999.00 and a performance period through December 31, 2025. This IDC serves as the primary contract vehicle for Amerisourcebergen to deliver pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.3k | 4/10/24 |